These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 35069590)

  • 1. T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
    Campe J; Ullrich E
    Front Immunol; 2021; 12():806529. PubMed ID: 35069590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Inflammatory T Helper Cells
    Buchele V; Abendroth B; Büttner-Herold M; Vogler T; Rothamer J; Ghimire S; Ullrich E; Holler E; Neurath MF; Hildner K
    Front Immunol; 2018; 9():1138. PubMed ID: 29910804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Fu J; Heinrichs J; Yu XZ
    Arch Immunol Ther Exp (Warsz); 2014 Aug; 62(4):277-301. PubMed ID: 24699629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
    Yao Y; Wang L; Zhou J; Zhang X
    J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.
    Mohamed FA; Thangavelu G; Rhee SY; Sage PT; O'Connor RS; Rathmell JC; Blazar BR
    Front Immunol; 2021; 12():757836. PubMed ID: 34712243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Casz1 as a Regulatory Protein Controlling T Helper Cell Differentiation, Inflammation, and Immunity.
    Bhaskaran N; Liu Z; Saravanamuthu SS; Yan C; Hu Y; Dong L; Zelenka P; Zheng L; Bletsos V; Harris R; Harrington B; Weinberg A; Thiele CJ; Ye F; Pandiyan P
    Front Immunol; 2018; 9():184. PubMed ID: 29467767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.
    Jiang H; Fu D; Bidgoli A; Paczesny S
    Front Immunol; 2021; 12():761448. PubMed ID: 34675938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
    Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, regulation and functional capacities of Th17 cells.
    Hirota K; Martin B; Veldhoen M
    Semin Immunopathol; 2010 Mar; 32(1):3-16. PubMed ID: 20107806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
    Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
    Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation.
    Sundrud MS; Grill SM; Ni D; Nagata K; Alkan SS; Subramaniam A; Unutmaz D
    J Immunol; 2003 Oct; 171(7):3542-9. PubMed ID: 14500650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
    Fowler DH; Gress RE
    Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity and plasticity of T helper cells.
    Zhu J; Paul WE
    Cell Res; 2010 Jan; 20(1):4-12. PubMed ID: 20010916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 CTL: living up to the challenge.
    Cheroutre H; Husain MM
    Semin Immunol; 2013 Nov; 25(4):273-81. PubMed ID: 24246226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role for donor-derived IL-22 in cutaneous chronic GVHD.
    Gartlan KH; Bommiasamy H; Paz K; Wilkinson AN; Owen M; Reichenbach DK; Banovic T; Wehner K; Buchanan F; Varelias A; Kuns RD; Chang K; Fedoriw Y; Shea T; Coghill J; Zaiken M; Plank MW; Foster PS; Clouston AD; Blazar BR; Serody JS; Hill GR
    Am J Transplant; 2018 Apr; 18(4):810-820. PubMed ID: 28941323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.
    Iclozan C; Yu Y; Liu C; Liang Y; Yi T; Anasetti C; Yu XZ
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):170-8. PubMed ID: 19804837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
    Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
    Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations.
    Zhao C; Zhang Y; Zheng H
    Front Immunol; 2021; 12():717540. PubMed ID: 34305954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
    Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
    Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.